Kia America, Inc.
Summary
NHTSA campaign 26V173: Kia America, Inc. recalled for a safety defect. A person, especially a child, may become trapped by a rear powered seat, increasing the risk of injury.
Details
Source
nhtsa
External ID
26V173
Action Date
2026-03-20
Status
Ongoing
Category
vehicle
Product Description
Kia America, Inc. (Kia) is recalling certain 2027 Telluride Hybrid SX Prestige and X-Line SX Prestige vehicles equipped with the Executive Package. The second-row power seats may fail to detect a person. The seat may continue to move after contacting a person during powered seat functions, such as one-touch tilt-and-slide or automatic power fold-and-stow.
Company
Context & Analysis
Kia America, Inc. has 70 FDA actions in our database.
Frequently Asked Questions
How often does Kia America, Inc. have FDA actions?
Kia America, Inc. has 70 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle